Provided by Tiger Fintech (Singapore) Pte. Ltd.

Karyopharm Therapeutics

3.85
-0.2200-5.41%
Post-market: 4.100.2500+6.49%18:03 EDT
Volume:151.97K
Turnover:613.20K
Market Cap:33.26M
PE:-0.31
High:4.17
Open:4.09
Low:3.85
Close:4.07
Loading ...
Sep 18, 2024

Major Issues Report

Form 8-K - Current report
Aug 29, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 05, 2024

Correspondence

Form CORRESP - Correspondence
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Correspondence

Form CORRESP - Correspondence
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]